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Abstract 
Patient portals are an important component for engaging patients in their own care. While providers are 
expected to implement patient portals to adhere to meaningful use guidelines, there has until recently 
been little research to demonstrate impact of the use of patient portals on patient care. This study 
leverages data from a regional diabetes clinic which contains record on over 44,000 registered diabetes 
patients. The data provide evidence that the frequency of use of a patient portal has a positive impact on 
clinical outcomes of diabetes patients. 
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Introduction 
Patient engagement is increasingly being recognized as a crucial component of a patient’s care routine 
(Forbat, Cayless, Knighting, Cornwell, Kearney, 2009; Coulter, 2002; Barello, Graffigna, Vegni, 2012). 
After leaving a physician’s office or hospital, patients are often the only individuals responsible for 
ensuring that they receive the proper care. The responsibilities placed on patients becomes increasingly 
burdensome as conditions become more severe or are accompanied by comorbidities. The amount of 
information and instructions patients must follow to adhere to evidence based practice guidelines is large 
and complex. Traditionally, a provider’s reach into a patient’s care would only extend as far as the doors of 
the facility in which they practice. This reach would occasionally extend into the patient’s home through 
phone calls when patients deemed an issue of high enough priority to warrant contacting a provider. A 
provider’s ability, however, to address all questions or concerns is limited. These time constraints have 
become greater as providers have had to take on larger volumes of patients to deal with a population that 
is acquiring chronic conditions at an increasing rate (Vogeli, Shields, Lee, Gibson, Marder, Weiss, 
Blumenthal, 2007). Technology is being used to aid providers in engaging patients in their own care. 
Patient portals, specifically, are being used to aid patients in keeping track of medication, appointments, 
test results, and other items related to the care of a patient (Kruse, Bolton, Freriks, 2015). Federal 
guidelines for electronic health record systems have set requirements related to the implementation of 
patient portal modules in existing systems. By 2017, providers are expected to implement APIs to 
electronic health record systems, allowing for third parties to write apps for mobile devices, increasing 
options for patients to be engaged in their own care. 
While these portals are believed to have an impact on patient care, there have been until recently few 
studies that have been able to provide evidence of this. This study adds to a growing body of evidence that 
patient portals have a positive impact on patient outcomes. Specifically, the study show support for 
frequency of use of patient portals impacting clinical outcomes of registered diabetics being treated in a 
regional diabetes clinic. 
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Background and Literature Review 
This study contributes to a body of evidence demonstrating the impact of patient portals on clinical 
outcomes. The impact of patient portal use on various dependent measures has been well explored, 
especially within the past five years. A literature search discovered 6 systematic reviews of studies that 
measure the impact of patient portals on some aspect of patient care (Ammenwerth, Schnell-Inderst & 
Hoerbst, 2011; Ammenwerth, Schnell-Inderst & Hoerbst, 2012; Otte-Trojel, de Bont, Rundall, van de 
Klundert, 2014; Goldzweig, Orshansky, Paige, Towfigh, Haggstrom, Miake-Lye,  Shekelle ,2013; Giardina, 
Menon, Parrish, Sittig, Singh, 2014; Kruse, Bolton, Freriks, 2015). In comparing findings from these 
reviews as well as exploring papers related to this area, there were 42 papers discovered that measured 
the impact of patient portals on some measure of care. There were 14 quantitative papers discovered that 
measured the impact of patient portals on a non-process based outcome of care. Of these 14, only 6 
involved measurement of impact on outcomes associated with diabetes. Most of these studies viewed use 
of the patient portal as a binary variable. The intent of this study is to go beyond looking at the use of 
portals as a binary variable and to determine whether the manner in which portals are used has an effect 
on clinical outcomes. Although there are a number of dimensions regarding the manner in which patients 
use portals that could be studied in this regard, this study focuses on the frequency with which portals are 
used and how this impacts patient outcomes. This has been done only in two prior studies (Osborn, 
Mayberry, Wallston, Johnson, Elasy, 2013; Tenforde,  Nowacki, Jain, Hickner, 2012). One of these studies 
provided support that more frequent users of patient portals had lower HbA1C measures, based on a self-
reported measure of  frequency of use (Osborn, Mayberry, Wallston, Johnson, Elasy, 2013). The other 
study provided support for greater change in HbA1C levels for users versus non-users, but found no 
evidence that greater use (as measured by time on the system) led to better outcomes (Tenforde,  
Nowacki, Jain, Hickner, 2012). To the author's knowledge, no study has yet been conducted which 
measures frequency of use as an objective measure and demonstrates that more frequent users have 
better outcomes, but also experience improvement in outcomes when participating in a care program. 
That is the finding reported in this study. 
Research Questions and Hypotheses 
The research question this study addresses is what effect patient portals have on clinical outcomes. 
Specifically being addressed is the effect that frequency of use of a patient portal has on clinical outcomes. 
Since the patient portal is designed with the intent of keeping patients engaged in the management of 
their conditions, and since patients who are more engaged are expected to have better outcomes, it is 
hypothesized that patients who are more frequent users of patient portals in general have better health 
outcomes than those who are less frequent users or non-users. 
H1: Frequency of use of a patient portal has a positive impact on clinical outcomes. 
A care plan for someone with a chronic disease has the intention of improving outcomes that are 
associated with a given disease condition. Patients are enrolled in a diabetes management program if they 
have clinical measures that place them into an at-risk category. The goal of such programs is to manage a 
patient’s condition in a way that will reduce the risk of patient experiencing a serious clinical incident. The 
easiest way to determine whether or not patients are managing conditions effectively is to observe the 
change in clinical outcomes. Providers of diabetes patients, for example, want to see HbA1C levels of their 
patients decrease as they participate in a care management program. Patients face clinical inertia when 
they are participating in a care management program without seeing any movement in their recorded 
clinical measures. The program is successful if a patient’s most recent clinical outcome measure is better 
than the measure taken at the date that they were enrolled into the program. Patient portals play a key 
role in this process. The patient portal is designed to ensure that patients are reminded of when to take 
medications, when to schedule appointments with specialists, as well as data regarding lab results. It is 
therefore expected that patients who frequently use the patient portal will see a greater improvement in 
clinical outcomes from the beginning of enrolling in a care program to the end.  
H2: Frequency of use of a patient portal has a positive impact on improvement of clinical outcomes. 
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Method 
This study leverages data on patients who were registered diabetics in a diabetes clinic serving a 
metropolitan area of roughly 2 million people. The patients used for the study were those that enrolled in 
a diabetes care management program. The program’s goal is to keep each patient’s diabetes under control, 
preventing patients from becoming higher risk patients and experiencing an event that could lead to 
hospitalization. The data were obtained from an Epic electronic health record system serving the hospital 
with which the diabetes clinic is affiliated. The data were obtained through the Clarity relational database 
which connects to Epic’s Chronicles database. SQL queries were constructed to pull data on patients who 
were part of the hospital’s diabetes registry, and enrolled to participate in the care management program. 
The timeframe of the data in the study includes a six year period ranging from 2011 to 2016. The data 
were limited to patients who had been enrolled in the program for only 6 months. 
To determine the effects of frequency of use on clinical outcomes, 6 analyses were run using multiple 
regression with clinical outcomes as the dependent variable, frequency of use of clinical portals as an 
independent variable among several other covariates which were also used as independent variables. The 
specific details on which measures were used is described below. To determine if these effects were 
different in patients of varying levels of acuity, the same analysis was conducted on patients of low HbA1C 
values (below 8), medium values (between 8 and 9) and high values (above 9). 
Clinical Outcomes 
There were three different clinical outcomes that were used in this study: HbA1C levels, LDL, and mean 
arterial blood pressure. These measures are recorded when patients enter the program and are recorded 
periodically throughout participation in the program. To determine the effect of patient portal use on 
outcomes in general, the most recent recording after program enrollment of each of these three measures 
was used. To determine the effect of patient portal use on improvement in clinical outcomes, the 
difference between the first recorded measure on or after enrollment and the last recorded measure after 
enrollment. 
Frequency of Patient Portal Use 
The Epic electronic health record system utilizes a patient portal feature known as MyChart. The system 
keeps logs related to patient use. For this study, the most recent access to MyChart was recorded for all 
patients enrolled in the diabetes management program. This most recent access was used as a proxy for 
frequency of use, as there were no additional data to calculate actual frequency. The use of this measure 
assumes that the proximity of patients’ most recent use of the system will give insight into how often they 
actually use the system. Patients were categorized based on how recently they last accessed the MyChart 
system. The categories used in the analysis were: Never accessed MyChart, accessed in the past 3 months, 
accessed in the past 3 months to 6 months, accessed more than 6 months ago. 
Covariates 
To account for other differences among patients, several covariates believed to have an effect on clinical 
outcomes were used in the regression analysis. These include age, gender, amount of time spent in a room 
with a primary care physician, the number of years since enrollment, whether or not the patient has seen 
an endocrine specialist, the type of insurance carrier the patient has (commercial or government), and the 
patient’s risk score as calculated by Epic. The age used in the analysis was age at enrollment into the 
program. The amount of time spent in a room by a primary care physician is a measure that comes from 
the Epic system and is measured from when a physician logs into the Epic system while seeing a patient 
until the time when the physician logs out. The measure used here was an average measure over all of the 
visits a patient had in the clinic from the time of enrollment. The number of years since enrollment was 
taken from the date of enrollment up to the date that the analysis was conducted. A visit to an endocrine 
specialist was retrieved from the Epic system using clinical specialty codes of physicians that visited 
patients during enrollment. Insurance carriers are documented within the Epic system. For the purposes 
of this study, the only factor used with respect to the carrier is whether or not the carrier was commercial 
or government. Commercial carriers often have incentives to reduce premiums based on management of 
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chronic conditions. The risk score calculated by Epic is intended to give an idea of how “at-risk” a patient 
is based on a number of metrics such as demographic metrics, utilization patterns, and clinical outcomes. 
The formula to calculate the risk is proprietary and has not been disclosed to the author of this paper.  
Results 
There were 44,055 patients who had enrolled in the program over the 6 year period from the beginning of 
2011 to the end of 2016. Excluding patients who had been enrolled for less than 6 months brought the 
number of patients to 36,254. Because the study measured the impact of portal use on various outcomes, 
only patients who had recorded values for these outcomes could be included in the study. This brought the 
total number of patients included in the study down to the number of observations reported in Tables 1-3. 
The results of the regression analysis on all patients is shown in Table 1. These results provide support for 
H1 by showing that patients who have used MyChart more recently have lower HbA1C results than those 
who do not use MyChart. The magnitude of the effect of MyChart decreases for people who have not 
accessed the system as recently. Those patients who have accessed the system in the past 3 months have 
on average an HbA1C final reading that is 0.322 points lower than those that do not use the system. This 
effect is slightly lower for those who have only used the system as recently as 3-6 months ago, having 
HbA1C readings that are only 0.303 points lower than non-users. Those that have had their most recent 
use more than 6 months ago only see a difference of 0.052 compared to non-users. This effect can also be 
observed for LDL and MAP, with those using the system within the past 3 months showing a significant 
difference while the difference for those from 3-6 months or greater than 6 months are non-significant. 
With respect to H2, this was not supported in the analysis that was run for all patients, as there was no 
effect of MyChart use on the change in any of the three clinical outcomes from the first to the last reading. 
The results for patients with medium level HbA1C values is shown in Table 2. These results provide 
support for H1 as related to HbA1C and LDL, although there does not appear to be any impact of MyChart 
use on MAP. There is also support for H2 in this table with respect to the change in HbA1C levels. Those 
who have used MyChart within the past 3 or from 3-6 months show a significant decrease in beginning 
and final HbA1C levels compared to non-users. Those who have not used the system in greater than 6 
months do not show a significant decrease compared to non-users. There is partial support for H2 with 
respect to changes in LDL as well. Although patients who have accessed the system in the past 3 months 
do not show a significant change in LDL compared to non-users, those who have used the system in the 
past 3-6 months show a significant change compared to non-users, while those who have not used the 
system in more than 6 months do not show as large of a decrease compared to those in the 3-6 months 
category. These results are comparable to those for patients with HbA1C levels greater than 9, shown in 
Table 3, which also provide support for H1 and H2, with respect to HbA1C, LDL, and changes in HbA1C 
and LDL. These results also show partial support for H2 with respect to changes in MAP. The patients in 
this group who have used MyChart within the past 3 months show significant changes in MAP, although 
oddly those in the 3-6 month group show a significant positive increase compared to non-users. The R-
squared values for all of these analyses are relatively low, which indicates that there are a number of out 
variables influencing these outcomes which have not been included in the model. 
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Dependent variable: 
 
Last HbA1C Last LDL Last MAP 
HbA1C 
Change 
LDL 
Change 
MAP 
Change 
Gender (Male) 0.110*** -9.215*** 0.794*** -0.037 0.948** -0.258 
Age -0.029*** -0.415*** -0.070*** 0.005*** 0.101*** 0.005 
PCP Time 0.003*** 0.085*** 0.010** -0.0002 0.029* -0.004 
Years Enrolled 0.118*** -1.666*** -0.169** -0.037** -1.156*** -0.350*** 
Endocrine Seen 0.335*** -3.931*** -0.871*** -0.440*** 0.897* -0.311 
Insurance (Govt) 0.039* -1.419*** -0.356** 0.051* 0.517 0.095 
Risk Score 0.060*** -2.180*** -0.988*** -0.077*** -1.027*** -0.493*** 
MyChart 0-3M -0.322*** -3.859*** -0.335** 0.013 0.256 -0.026 
MyChart 3-6M -0.303*** -1.026 -0.429 -0.011 -1.548 0.136 
MyChart> 6M -0.052* 0.581 0.049 0.039 0.641 0.218 
Constant 8.441*** 121.836*** 99.009*** -0.302*** -10.508*** -0.344 
 Observations 24,215 24,303 24,356 24,191 24,303 24,356 
R2 0.084 0.058 0.027 0.012 0.003 0.002 
Adjusted R2 0.084 0.058 0.027 0.011 0.002 0.002 
F Statistic 223.148***  149.336*** 67.854*** 28.252***  6.643*** 4.930*** 
 Note: *p<0.1; **p<0.05; ***p<0.01 
Table 1. Regression Results for All Patients 
 
 
 
Dependent variable: 
 
Last HbA1C Last LDL Last MAP 
HbA1C 
Change 
LDL 
Change 
MAP 
Change 
Gender (Male) -0.058 -10.992*** 0.826** -0.063 2.272* -0.533 
Age -0.016*** -0.412*** -0.036** -0.014*** 0.101* 0.018 
PCP Time 0.004** 0.100** 0.028** 0.004** 0.013 0.002 
Years Enrolled 0.031 -0.016 -0.354 0.021 -0.911 -0.523* 
Endocrine Seen 0.006 -5.115*** -1.254*** -0.033 2.388* -0.012 
Insurance (Govt) 0.065 -2.968** -0.802* 0.056 0.085 -0.042 
Risk Score -0.005 -2.705*** -0.990*** -0.009 -1.681** -0.415 
MyChart 0-3M -0.349*** -4.223*** -0.455 -0.330*** -0.639 -0.240 
MyChart 3-6M -0.393*** -2.873 -1.117 -0.366*** -5.697* -0.482 
MyChart> 6M -0.123* -2.481 -1.215** -0.108 -1.874 -0.187 
Constant 8.692*** 119.156*** 97.357*** 0.186 -9.677** -1.404 
 Observations 3,005 2,998 3,005 3,005 2,998 3,005 
R2 0.035 0.068 0.025 0.029 0.005 0.002 
Adjusted R2 0.032 0.065 0.022 0.026 0.002 -0.001 
F statistic 10.800*** 21.880*** 7.723*** 9.023*** 1.542 0.685 
Note: *p<0.1; **p<0.05; ***p<0.01 
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Table 2. Regression Results for Patients with HbA1C Between 8 and 9 
 
Dependent variable: 
 
Last HbA1C Last LDL Last MAP 
HbA1C 
Change 
LDL 
Change 
MAP 
Change 
Gender (Male) -0.174*** -10.287*** 1.566*** -0.105 3.688*** 0.864** 
Age -0.038*** -0.508*** -0.060*** -0.017*** -0.105* -0.046** 
PCP Time 0.005** 0.057 0.025** 0.003 0.035 0.011 
Years Enrolled 0.046 -0.495 0.016 0.027 -0.861 -0.195 
Endocrine Seen -0.134** -4.906*** -0.802** -0.246*** 0.232 0.041 
Insurance (Govt) 0.016 -1.528 -0.449 0.007 3.222** 0.568 
Risk Score 0.097*** -2.683*** -0.403** -0.021 -2.098*** -0.204 
MyChart 0-3M -0.567*** -5.716*** -0.525 -0.372*** -3.438** -1.049** 
MyChart 3-6M -0.621*** -0.316 0.835 -0.458** -6.497* 2.026* 
MyChart> 6M -0.028 -1.365 0.315 0.042 0.334 0.304 
Constant 10.527*** 130.130*** 97.026*** -1.212*** -4.340 -0.436 
 Observations 3,940 3,927 3,940 3,940 3,927 3,940 
R2 0.072 0.061 0.019 0.020 0.009 0.006 
Adjusted R2 0.070 0.058 0.016 0.017 0.006 0.004 
F statistic 30.677*** 25.277*** 7.569*** 7.935*** 3.403*** 2.449*** 
Note: *p<0.1; **p<0.05; ***p<0.01 
Table 3. Regression Results for Patients with HbA1C > 9 
 
Discussion 
The purpose of this study is to demonstrate the frequency of use of a patient portal system can have an 
impact on clinical outcomes. While prior studies have shown an effect of patient portals on some 
outcomes, none have explored the frequency of use itself as a variable. The study provides support for the 
impact that frequency of use has on both measured outcomes as well as change in outcomes from the 
beginning of participation in a diabetes management program to the most recent measurement of a given 
outcome. The study has important implications for healthcare providers, payers and patients. The 
implications for providers and patients are perhaps straightforward. For providers, implementing and 
encouraging patients to use a patient portal system could aid them in moving patients towards better 
results. For patients, signing up for and using these systems on a regular basis should lead to better 
results. 
The results of the study may have the most significant implication for payers. While moving patients 
towards better outcomes is in the interest of all parties, payers are put in the position of providing 
incentives to patients to engage in the management of conditions. The incentives can involve lower 
premiums for those who receive annual exams, higher copays for specialist visits, and discounts for using 
providers who belong to the payer network. Payers also provide incentives for patients who complete 
online risk assessments. It is reasonable to believe that payers may in the future provide incentives to 
patients who use portals. To do this, payers would need information to inform the structure of the 
incentive. For example, is creating a portal account a sufficient action to warrant an incentive to a patient? 
Should patients be required to log into a portal system at a particular frequency to receive incentives? If 
so, how often. This study provides insight that may aid payers in making such decisions. Payers could 
construct incentives based on existing patient attributes. For example, patients with a goal of controlling 
HbA1C levels may only need to be encouraged to use the portal every 3-6 months, since more frequent use 
does not seem to provide a much larger benefit. 
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Limitations 
The findings of this study do have limitations. The chief limitation is that the study is not a randomized 
controlled trial. The patients who use the MyChart system, and those who choose to use it more frequently 
are self selected. This makes it difficult to demonstrate a causal relationship between MyChart use and 
outcomes. That is, patients may be using the system because they are more conscientious or have other 
attributes which make them better managers of their condition, and it is these same attributes that leads 
them to use the MyChart system more frequently. 
The measurement of MyChart use is also a limitation in this study. The data were gathered for a clinician 
to optimize diabetes care, and thus less focus was placed on the use of patient portals. Thereby, the only 
attribute available for analysis was the last access to the MyChart system. While this was used as a proxy 
for frequency of use, it is not a true measure of frequency of use. This could have some effect on the 
results. 
Future Research 
In addition to future research projects which could be carried out to address the limitations described 
above, there are also other aspects of patient portal appropriation that may affect the impact of portal use 
on patient outcomes. Aside from frequency of use, it would be interesting to see which components of 
patient portals are having the largest impact on outcomes. Why are patients benefitting from use of the 
system? Is it that they are receiving alerts and provider messages? Is it the convenience of being able to 
set up an appointment online? Is it the ease of access to results? Further, understanding provider 
attributes or patient attributes that could affect the manner in which patient portals are used and how this 
use impacts outcomes would also be of interest. 
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